Deep-Brain Stimulation Curbs Some Parkinson’s Symptoms, Not All – NEJM
This article was originally published in The Gray Sheet
Executive Summary
Relatively young patients may prove the best candidates for subthalamic nucleus stimulation therapy to treat Parkinson's disease, researchers write in the Nov. 13 issue of The New England Journal of Medicine
You may also be interested in...
Activa Deep-Brain Stimulation Coverage Includes Provider, Facility Criteria
CMS will monitor results of two long-term clinical studies evaluating "optimal targeting" for deep-brain stimulation to treat Parkinson's disease and essential tremor, following a positive national coverage determination
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.